US General Surgical Devices Market 2026 – 2035

The general surgical devices market size in the US is estimated to be USD 18.42 billion in 2025 and it is projected that such a market size will swell to USD 19.86 billion in 2026 and to about USD 35.28 billion between 2026 and 2035 with an annual CAGR of 7.8%.

The market is expanding due to the rising number of surgical operations due to the aging population, the rising incidence of chronic conditions that require surgical services, technological innovation in the field of minimally invasive surgery and robotic surgery platforms, the growing number of ambulatory surgical center infrastructures, and the wider application of single-use expendable surgery equipment to control the transmission of infection.

Market Highlight

• The market of US general surgical devices had a leader in the Northeast region with a market share of 32% in 2025.

• It is seen that the West region will increase by 8.9% between 2026 and 2035.

• By product type, the surgical sutures & staplers segment had gained 24% of market share by the year 2025.

• Application Cardiovascular surgery segment will have the highest CAGR of 8.6% between the years 2026 and 2035.

• Surgery type-wise, the most promising CAGR is expected to be in surgery type, where the segment with the minimally invasive surgery will have 9.2% over the forecast period, 2026-35.

• By end user, in 2025, 64% of the market was controlled by hospitals.

• By 2024, it is estimated that the United States conducted 48.3 million inpatient and outpatient surgeries, of which 62% of the potential surgeries were done using a minimally invasive method.

Significant Growth Factors

• Aging Population and Rising Surgical Procedure Volumes:

The demographic transition to older populations in the United States creates significant growth in the volumes of surgery operations since the diseases that necessitate surgical intervention as a result of age gain momentum. According to the US Census Bureau, there were 58.2 million Americans who were aged 65 and above in 2024 and this is 17.3% of the total population and is expected to increase to 82.1 million in 2040 and form 22.6% of the total population. According to the Agency for Healthcare Research and Quality data, the rates of undergoing surgical procedures rise exponentially with age, with Americans aged above 65 having rates 3.8 times as high as those of 45-64 years and 8.2 times higher than anyone under 45. Inpatient and outpatient combined surgical operations were 48.3 million in 2024, and the trend shows that it is growing at a rate of 2.8% each year during the last five years, so the figure will reach 61.4 million procedures by 2035, which is mainly due to the aging population.

Ordinary surgical operations such as coronary artery bypass surgery, which is conducted on 371,000 patients every year, hip surgery in 520,000 patients, knee surgery in 790,000 patients, and cataract surgery in 3.8 million patients generate a steady market for surgical equipment where the average cost of a device is between $850 and $4,200 depending on the complexity of the surgery. Chronic disease rates necessitating surgical intervention are on the increased trend, with diabetes at 38.4 million users (11.6% of the population), creating a wound care and vascular surgery equipment demand, cardiovascular disease at 127.9 million adults requiring bypass, valve replacement, and interventional intervention; and cancer at 18.1 million survivors with 2 million new cases annually necessitating oncologic surgery. The impact of the obesity epidemic on 41.9% of the adult US population contributes to the volume of bariatric surgeries of 278,000 in 2024, each benefiting from specialized equipment such as trocars, staplers, and energy devices, worth up to $3,500-6,800 per case.

• Expansion of Ambulatory Surgical Centers and Outpatient Procedures:

The strategic change in the inpatient hospital environment to the ambulatory surgical center to perform the right surgeries changes the market dynamics of surgical devices with high volume of procedures, cost pressures and the urge to use single-use disposable devices. By 2024, there were 6,140 Medicare-certified ambulatory surgical centers, up from 5,830 in 2019, and a total of 9,800 ASCs were operating throughout the nation (including non-Medicare-certified ones). In 2024, ASCs conducted 28.4 million procedures (59 out of every 100 operations) of outpatient surgery, and technology has advanced to allow patients more complex procedures in the outpatient setting and patient pressures have led to the growth in ASCs because CMS has been increasing reimbursement, and patients prefer more convenient and less expensive care.

The average cost per procedure of surgery devices at ASCs stands at 1240, which is 30-40 cheaper than the 1850 price of the outpatient department at the hospital because of strong price negotiation, use of less expensive alternatives, and managing the inventory in a simple manner. This movement of single-use disposable devices gains more momentum in ASC environments where there is no economic efficiency in reusable instrument reprocessing facilities at lower volumes of procedures and where adoption of a disposable device is 78% in ASCs and 56% in hospitals. Changes in CMS payment policy increased the number of ASC-eligible procedures in 2024, not less than 3,594 (it was 1,962 in 2019), including total knee replacement, spine fusion, and other previously inpatient-only procedures that had created new device market opportunities. In 2024, Medicare ASC spending amounted to 5.8 billion, and surgical device costs form about 18-24% of the total procedure costs comprising the addressable market segment of 1.04-1.39 billion. In 2024, 18-25% EBITDA margins have been used to attract private equity investment in ASC development, which has been funding 420 new centers and expansions of existing facilities, which has continued to expand the market.

• Technological Innovation in Minimally Invasive and Robotic Surgery:

Minimal Surgery Technology Minimally invasive surgery, as well as robotic surgery, is a transformative revolution in surgical procedures, patient care, and the demand for specialized equipment and accessories. Minimally invasive procedures in surgery came to a high of 29.9 million in 2024, or 62% of the total number of eligible procedures, as opposed to 42% in 2015, due to established advantages of 50-70% of hospital stays averaging 1-2 days compared with 4-6 days, 60-75% less postoperative pain and opioid use, 40-55% reduced complication rates, and an average of 2-3 weeks to normal activities, compared with The use of sophisticated laparoscopic equipment such as the articulating devices of 7 degrees of freedom, ultra- high-definition 4K imaging devices, and energy devices with a combination of ultrasonic and bipolar techniques applies complex procedures, which could only be achieved through open procedures.

As of 2024, the robotic surgery market in the United States had a value of 4.8 billion, and it had an estimated number of 3,800 Intuitive Surgical da Vinci systems, 145 Medtronic Hugo systems, and emerging competitors of CMR Surgical, Johnson & Johnson, and others. Robotic procedures reached 1.85 million in 2024, with growth of 14.2% per year, and the average disposable instrument costs per procedure are 2400-3800 which make up a good portion of the consumables market whether capital equipment is being sold or not. Single-port robotic systems such as da Vinci SP can be used to operate with a single 25mm incision over the traditional 4-5 ports with better cosmetic results and reduced trauma, and 68,000 procedures were done in 2024, mainly in the urologic and colorectal specialties. The computer-aided navigation systems combined with the surgical instruments are used to orally guide during the orthopedic, spinal, and neurosurgical operations, and 12,400 navigation-assisted operations were conducted monthly, leading to an improvement in accuracy and a decrease in complications by 22-34% in complicated anatomy.

• Emphasis on Infection Prevention and Single-Use Devices:

This concerns Infection Prevention and Single-Use Devices: There is increased focus on the prevention of healthcare-associated infections and regulatory pressure on patient safety, which will result in increasing the adoption of single-use disposable surgical devices that eliminate cross-contamination risks of reusable instruments. According to the estimates of the Centers for Disease Control and Prevention, 687,000 healthcare-associated infections in US acute care hospitals are estimated to happen every year, of which surgical site infections constitute 157,500 cases (23) that incur 3.3 billion dollars of unnecessary medical costs and 8,200 deaths. Single-use surgical equipment removes the risk of infection transmission during reprocessing, and research indicates that there is residual bioburden on 8-15% of reusable equipment despite confirmed cleaning protocols and prion contamination risks in neurosurgery where the conventional technique of sterilization is insufficient.

The single-use surgical device market is 8.4 billion in 2024 and is expected to grow by 11.6% a year as hospitals and ASCs switch to reusable tools, with laparoscopic trocars, energy tools, and specialty instruments being the most popular. Economic study shows that single-use devices will be cost competitive or less expensive than reprocessing when the cost of reprocessing, which is estimated to be on average 185-340 per instrument cycle including labor, sterilization supplies, equipment depreciation, and quality control, especially in the low-volume cases where reusable instrument use is less than 15-20 cases per year. Such regulatory measures as FDA Safety Communications on the problem of duodenoscope-related infections and flash sterilization of surgical instruments promote the adoption of single use as hospitals are getting rid of high risk reprocessing. Ecological concerns question the idea of single-use expansion because each day 6,600 tons of medical device waste are produced in US hospitals, which makes the creation of sustainable materials such as bio-based polymers, recyclable parts, and take-back programs to retrieve precious materials of the used devices come into the picture.

What are the Major Advances Changing the US General Surgical Devices Market Today?

• Advanced Energy-Based Surgical Devices and Vessel Sealing:

The next generation energy platforms with ultrasonic, bipolar, and monopolar modalities built into a variety of tools offer surgeons with one instrument a wide range of tissue dissection, coagulation, and vessel sealing in a variety of surgical applications. In vessels up to 7 mm in diameter, advanced bipolar vessel sealing systems demonstrate permanent seal strength over 950 mmHg, eliminating the need to use sutures and clips and reducing the amount of time needed to achieve the required extensive amount of hemostasis, such as in thyroidectomy, hysterectomy, and colorectal resection. Ultrasonic dissection systems with 55.5 kHz frequency cut tissue by cavitation with minimal lateral thermal spread of 0-2 mm compared with 5-15mm with monopolar electrosurgery, permitting dissection of the tissue around important structures such as nerves and blood vessels.

The variability of ultrasonic and advanced bipolar energy in single instruments is available in combination devices, with market leading platforms provided by Medtronic (Sonicision), Ethicon (Harmonic), and Olympus (Thunderbeat) showing 15-22% faster procedure completion than single-energy devices. Energy devices that have smoke evacuation systems remove 95-98% of the surgical plume that may contain potentially harmful particulates, volatile organic compounds, and live cellular material, which addresses the issue of occupational health of 500,000 healthcare workers that breathe the surgery plume each year. By 2024 the advanced energy device market had reached 2.8 billion dollars with a recurring revenue business model through its disposable components, as the devices need replacement after either 10 or 30 uses depending on the design, creating a razor-razorblade business model with the instruments selling at 1,800-3,200 and generators at 12,000-28,000. Energy tools powered by batteries are cordless to remove the weight of cables, which enhances the ergonomics of surgery and speeds up the setup time, and the lithium-ion batteries offer 60-90 minutes of continuous operation, which is adequate in most operations.

• Smart Surgical Instruments with Integrated Sensors:

Surgical instruments that incorporate sensors, microprocessors, and connectivity will produce intelligent tools that can provide timely feedback, be safe, and record the information to improve quality and be used for training. Medtronic, Ethicon, and others have smart stapling devices with tissue thickness sensors that automatically regulate the staple height and compression with respect to variable tissue density to minimize leaks of staple lines by 5.8 to 1.2% of gastrointestinal anastomoses. Surgical retractors that are pressure-sensitive detect the amount of force used on tissues and give a signal to the surgeon when they are at risk of causing nerve damage or ischemia, and neurosurgery systems have reduced permanent neurological deficits in complex exposures to 1.8% instead of 4.2%.

The RFID tag attached to instruments allows automated inventory visibility, which ensures that each instrument is accounted for to prevent an instrument from remaining in use, which might have an impact on 1 in 5,500 procedures, and the use of instruments minimizes wastage of money spent on carrying extra inventory. High-tech electrosurgical generators that monitor variations in tissue impedance and automatically adjust power flow to avoid tissue charring and sticking and maximize energy use with reduced median operative bleeding by 40% and an average reduction of 12 minutes. The surgical instrument connectivity captures data on surgical instrument use, activation, and performance parameters to generate digital surgical records that can support quality improvement, credentialing, medicolegal documentation, and cloud-based solutions that combine data related to 840,000 surgeries each month to determine best practice and performance variation. The integration of artificial intelligence is capable of real-time surgical video and instrument data analysis with decision support, anatomical structure detection, and the potential complications warning to the surgeons, and pilot studies in cholecystectomy showed a reduction of bile duct injury rates, 68%, with early warning systems integrated.

• Advanced Wound Closure Technologies and Tissue Adhesives:

Groundbreaking wound closure technologies and tissue adhesives enhance wound healing, decrease time spent on the procedure, enhance cosmetic outcomes, and increase the range of possibilities of complex wound and minimally invasive access site closures. Microscopic barbs on barbed sutures, eliminating the need to tie knots, decrease fascial and dermal layer closure time by 35-50% and evenly distribute tension along the length of the incision, with adoption rates of 28% of abdominal wall closures in 2024 and rising at a rate of 18% per year. Knotless tissue control systems such as V-Loc (Medtronic) and Stratafix (Ethicon) are found to have an equal or greater tensile strength than conventional knotted sutures and eliminate 4-7 minutes per layer of closure and hand fatigue in long surgeries. Synthetic tissue adhesives such as cyanoacrylate and polyurethane versions offer waterproof seals within 30-60 seconds of application time, which can otherwise be very difficult in pediatric surgery with traditional sutures and is of particular use in the market of tissue adhesive as well as reaching a 420 million dollar market by 2024.

Hemostatic agents such as oxidized cellulose, gelatin-thrombin complexes, and flowable hemostats provide hemostasis within 2-4 minutes in oozing surfaces, and traditional sutures and cautery are ineffective, and transfusion is reduced by 30-45% in cardiac and hepatic surgery. Skin closure tools such as self-adhesive strips, zip-type closures, and special staples used to apply to the skin enhance cosmetic effects and reduce the closure time by 60–75% relative to subcuticular suturing and have a higher patient satisfaction score of 7.2/10 and 8.8/10 respectively. Triclosan-impregnated antimicrobial sutures are shown to reduce surgical site infections in the contaminated wounds and high-risk patients by 30-45%, and cost analysis of their use demonstrates them to be cost-effective when used regularly in colorectal, emergency, and oncologic surgical procedures where infection rates are more often than not larger than 12-18%.

• Portable and Point-of-Care Surgical Technologies:

Miniaturization and integration of technologies allow the creation of portable surgical technologies, transforming care delivery to non-traditional areas such as ambulatory clinics, emergency departments, and the field of military medicine, as well as resource-restricted environments. Monopolar and bipolar electrosurgical units as small as 2-4 kg and powered by rechargeable batteries are available, which offer limited power at the cost of less than $3,800-8,200 apiece, compared to traditional operating room generators, which cost up to $18,000-35,000. Smaller surgical lighting systems with LEDs are available that offer 100,000 lux of light in a small form factor that fits in a field surgery and can be used in non-operating room procedures, and they operate 8-12 hours on a battery.

Surgical planning Anatomical visualization, vascular mapping, and procedural direction in point-of-care ultrasound are available without specialized imaging suites or costly devices (priced at $5,000-12,000) and enable real-time visualization of the anatomy, vascularity, and procedural direction. In battery powered or manual operation mode, portable surgical suction units can deliver 25-30 inHg vacuum that is applicable to most procedures needed in trauma care, emergency care, and field medicine. The integration of telemedicine allows remote surgeries with high-definition video, annotations, and bi-directional communication to support procedures in underserved locations, military, and disaster response, and telementoring platforms have already been applied in 18,400 procedures in 2024, which have shown an average of 32% improvement in outcome when compared to historically controlled results of the same procedure.

Category Wise Insights

By Product Type

Why Surgical Sutures & Staplers Lead the Market?

The surgical suture and staple products are projected to have a market share of 24 in 2025 because their use is mandatory in all surgical specialties, it is heavily used with an average of 12-18 suture packets per surgery, and they are innovated with new materials and designs. In 2024, the US sutures and staplers business hit a record of 4.42 billion, with absorbable sutures taking 62% of that market due to benefits such as no removal, predictable absorption kinetics, and material development such as antibacterial coatings and barbed designs. High-tech staplers with tissue thickness sensors, articulating tip to serve in limited areas, and reload systems to enhance ergonomics have high prices of between 180-420 reload, compared to the conventional models at between 85-140 reload. The typical hospital that makes 8,200 surgeries each year uses sutures worth a total of 820,000-1.2 million and staplers worth 450,000-780,000, which is 18-22% of all surgical device expenditure. Material science progresses, such as synthetic absorbable polymers with degradation profiles ranging between 14 days and 180 days, allow the surgeons to make suture retention comparable to the tissue healing properties to achieve optimal results.

By Application

Why Cardiovascular Surgery Shows Fastest Growth?

The highest CAGR is recorded in cardiovascular surgery of 8.6% between 2026-2035 with the rise in prevalence of heart disease that impacts 127.9 million Americans, an aging population where 85% of cardiac surgeries are administered to patients older than 55, and the emergence of technologies that make heart surgery procedures more minimally invasive that broadens the potential patient base. There are 371,000 annual coronary artery bypass procedures that involve the use of special surgical equipment such as sternal saws, retractors, and vessel harvesting systems that cost 2800-4600 per case. Valve replacement and repair surgery that costs up to 178,000 a year includes advanced sutures, special retractors, and minimal access systems with a device price of 3200-5800/procedure. The transcatheter and minimally invasive cardiac surgery development is increasing from 24% of valve operations in 2019 to 48% in 2024, to create new market segments as specialized ports, endoscopes, and miniaturized tools are in demand.

By Surgery Type

Why Minimally Invasive Surgery Demonstrates Strong Growth?

The highest CAGR of 9.2% between 2026 and 2035 is due to the fact that minimally invasive surgery may remain to be converted into the open method, more technology allows complex surgeries to be performed, and there are clinically and economically significant reasons. MIS surgery hit 29.9 million in 2024 making 62% of the eligible surgeries with conversion rates of 85% in bariatric surgery to 35% in complex oncologic procedures. The average cost per MIS procedure of devices per procedure is higher (3,200-5,800) as compared to similar open surgery procedures (1,800-3,200), which is due to the specialized trocars, energy devices and visualization systems but when the entire episode is considered, it is still less (25-40) as compared to 1,800-3,200. The market of single-use laparoscopic instruments had reached a market of 2.8 billion dollars in 2024 and is projected to grow 12.4% a year as hospitals switch to single-use instruments to avoid reprocessing and the risk of infections.

Report Scope

Top Players in the Market

• Medtronic plc

• Johnson & Johnson (Ethicon)

• Stryker Corporation

• B. Braun Melsungen AG

• Becton Dickinson and Company

• Smith & Nephew plc

• Zimmer Biomet Holdings Inc.

• 3M Company

• Integra LifeSciences Holdings Corporation

• ConMed Corporation

• Teleflex Incorporated

• Applied Medical Resources Corporation

• Others

Key Developments

• In October 2025: Medtronic Hugo RAS robotic surgery system can be commercialized in the United States, with initial sites planned in 85 hospitals in 2025 and costing 30% less than da Vinci systems that might open robotic surgery to more.

• In June 2025: Johnson and Johnson , in its Ethicon division, introduced next-generation Echelon staplers, which use AI-controlled tissue analysis to provide real-time feedback on the best firing parameters and which showed a 35% decrease in staple line complications in clinical trials.

These are the strategic actions that have enabled companies to leverage into better market positions, product diversification, improved technological capacity, and exploitation of growth opportunities in the changing US general surgical devices market.

The US General Surgical Devices Market is segmented as follows:

By Product Type

• Surgical Sutures & Staplers

  • Absorbable Sutures

  • Non-Absorbable Sutures

  • Surgical Staplers

• Handheld Surgical Instruments

  • Forceps & Clamps

  • Scalpels & Blades

  • Scissors

  • Retractors

• Electrosurgical Devices

  • Monopolar Devices

  • Bipolar Devices

  • Ultrasonic Devices

• Surgical Kits

• Disposable Surgical Supplies

• Others

By Application

• Cardiovascular Surgery

• Orthopedic Surgery

• Neurosurgery

• Plastic & Reconstructive Surgery

• General Surgery

  • Abdominal Surgery

  • Bariatric Surgery

  • Colorectal Surgery

• Others

By End User

• Hospitals

• Ambulatory Surgical Centers

• Specialty Clinics

• Others

By Surgery Type

• Open Surgery

• Minimally Invasive Surgery

• Robotic-Assisted Surgery